THE WHAT? BASF and Henkel have announced a joint commitment to replace fossil carbon feedstock with renewable feedstock for most products in Henkel’s European Laundry & Home Care and Beauty Care businesses over the next four years.
THE DETAILS The decision follows a successful pilot with Henkel’s cleaning and detergent brand Love Nature in 2021.
Through the cooperation, the fossil feedstock for around 110,000 tons of ingredients per year will be substituted with renewable feedstock using BASF’s certified biomass balance approach. As a result, Henkel’s core brands like Persil, Pril, Fa and Schauma will come with a reduced carbon footprint, avoiding around 200,000 tons of CO2 emissions in total.
According to a press release, “BASF has established a closed chain of custody from the renewable feedstock it uses through to the final product. TÜV Nord, an independent certification body, supports the practical implementation and confirms according to the REDCert2 certification scheme that BASF replaces the required quantities of fossil resources for the biomass balanced product with renewable feedstock.”
THE WHY? Carsten Knobel, CEO of Henkel, said, “To foster a regenerative planet, we are on a journey toward an environmental transformation of our business model. We intend to continuously enhance our processes, products and use of raw materials for a resource-efficient, carbon-neutral future. Integrating BASF’s biomass balance approach into our supply chain as an early-mover is a right step in that direction.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
